ADMA Biologics, Inc. (ADMA)
9.71
+0.45
(+4.86%)
USD |
NASDAQ |
Apr 08, 12:54
ADMA Biologics Cash from Investing (TTM) : -21.89M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Inovio Pharmaceuticals, Inc. | 14.04M |
| ANI Pharmaceuticals, Inc. | -34.32M |
| AtriCure, Inc. | -14.55M |
| Ligand Pharmaceuticals, Inc. | -377.32M |